Evidence map›Paper›PMID 41959730›Full record

ArticleJournal of the Georgia Public Health Association2025

COVID-19 Vaccine Acceptance among People who Smoke in Rural Southwest Georgia: Perspectives and Influencing Factors.

Shadé Owolabi, Helen Singer, Katherine Reilly, Lucja T Bundy, J K Veluswamy, Carla Berg, Regine Haardörfer, James Hotz, Ajay Gehlot, Michelle Kegler

Abstract read
In one paragraph

Article in Journal of the Georgia Public Health Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shadé OwolabiEmory Prevention Research Center, Rollins School of Public Health, Emory University, Atlanta, GA.
Helen SingerEmory Prevention Research Center, Rollins School of Public Health, Emory University, Atlanta, GA.
Katherine ReillyEmory Prevention Research Center, Rollins School of Public Health, Emory University, Atlanta, GA.
Lucja T BundyEmory Prevention Research Center, Rollins School of Public Health, Emory University, Atlanta, GA.
J K VeluswamyHorizons Community Solutions, Inc., Albany, GA.
Carla BergDepartment of Prevention & Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC.
Regine HaardörferEmory Prevention Research Center, Rollins School of Public Health, Emory University, Atlanta, GA.
James HotzAlbany Area Primary Health Care, Albany, GA.
Ajay GehlotCareConnect Health, Cordele, GA.
Michelle KeglerEmory Prevention Research Center, Rollins School of Public Health, Emory University, Atlanta, GA.

Funding

Intergrating a Smoke-Free Home Intervention into the 5As to Support CessationR01CA235721 · NCI · EMORY UNIVERSITY · PI KEGLER, MICHELLE C · 2019 to 2024
$2.9M
NCI NIH HHS R01 CA235721
6 · The paper itself

Abstract

Background: The COVID-19 vaccine is a critical tool in reducing COVID-19 related morbidity and mortality. Unfortunately, vaccine hesitancy is an ongoing public health challenge, especially in certain geographic areas and sub-populations. This study assessed factors associated with COVID-19 vaccine uptake and hesitancy among individuals who smoke in rural communities in southwest Georgia, one of the first COVID-19 "hot spots" in the U.S. Methods: We conducted qualitative interviews (n=23) using a semi-structured interview guide, informed by the Integrated Behavioral Model (IBM), that assessed vaccine-related behavior, intention to be vaccinated, perceived risk, social norms, attitudes, and environmental barriers and facilitators influencing vaccine hesitance and uptake. Results: Participants were 46 years old on average (SD=9.9; range: 25-63), 82.6% female, 60.9% Black, and 43.5% with an annual income <$25,000. Slightly over half (56.5%) had received at least one dose of the vaccine, 17.4% planned to, and 26.1% were unsure or did not plan to. Generally, participants acknowledged that those who smoke were at risk for worse COVID-19 related outcomes. Positive attitudes toward vaccination included reduced stress or concern about contracting and/or spreading the virus, less worry about becoming severely ill and/or dying from the virus, and reduced stress about socializing and inviting people over. Negative attitudes commonly focused on the speed of vaccine development and unknown long-term side effects, but also included distrust of government, fear of getting the virus from the vaccine, fear of needles, conspiracy theories, and dislike of mandates. Normative influences, most often from family members, were especially salient in the decision to get the vaccine, as was "doing research." Conclusions: Current results uncovered several salient factors aligning with IBM that should be considered when addressing vaccine uptake and hesitancy among priority populations, particularly those in rural areas who smoke, and improving vaccination outreach efforts.

Indexed as

COVID-19Integrated Behavioral ModelRuralSmokingVaccineVaccine HesitancyVaccine Uptake

Identifiers

PMID41959730
PMCPMC13061337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.